BRO vs COLL · P/E 30, rev $4.80B vs P/E 17, rev $181.9M
Brown & Brown Inc (BRO) versus Collegium Pharmaceutical Inc (COLL) — a side-by-side from cached financials, not a winner call.
Brown & Brown Inc (BRO) is a insurance brokers company listed on US.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported BRO revenue for 2024-12-31 was $4.80B. Net income was $1.00B. Revenue was up 12.9% from 2023-12-31 to 2024-12-31. BRO currently screens at market cap $35.56B and trailing P/E 30.0.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
BRO currently screens at market cap $35.56B and trailing P/E 30.0. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Not investment advice. Open the BRO and COLL stock pages for the full models.
Not investment advice.